InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Broom Colin MD, Director. Officer active across 1 company, notably Nabriva Therapeutics plc. In total, 5 filings have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €2k. Activity tracked since 28 July 2021. The latest transaction was disclosed on 2 August 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations5 total
5,339 shares@ US$0.190248.2% of flowOrdinary SharesSEC:0001104659-22-086280:0
531 shares@ US$1.2050.0% of flowOrdinary SharesSEC:0001104659-21-100289:0
531 shares@ US$1.2025.9% of flowOrdinary SharesSEC:0001104659-21-100289
17,500 shares0Ordinary SharesSEC:0001104659-21-098428
17,500 shares0Ordinary SharesSEC:0001104659-21-098428:0
5 of 5 declarations
About Broom Colin MD
Broom Colin MD is a Board Member at Nabriva Therapeutics plc. In this role, he brings his expertise in biotechnology and healthcare, contributing to the strategic direction of the company. His experience in pharmaceutical research and development is a valuable asset to the board, guiding decisions related to innovation and regulatory compliance.
